The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded Encephalogix, Inc. a $459,994 Project Grant to support epilepsy research. The award, effective from Sep 1, 2024 to Aug 31, 2025, will fund the company's "Epilepsy Research Program Idea Development Award" to explore innovative approaches to the prevention, diagnosis, treatment, and management of epilepsy, a condition relevant to military personnel and veterans. The Military Medical Research and Development program, administered by the Defense Health Agency, focuses on transforming healthcare for Service Members and the general public through advanced biomedical research initiatives spanning basic, applied, and translational science across various medical disciplines.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $460.0k | 7/31/24 |